Cargando…
Fibrinolytic Changes in Women with Preeclampsia
OBJECTIVES: Preeclampsia (PE) is a serious complication of pregnancy. The fibrinolytic system play crucial roles regarding placentation and evolution of PE. AIM: To study comprehensively components of the fibrinolytic system and fibrin lysability in women with PE. DESIGN AND METHODS: 117 women with...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558852/ https://www.ncbi.nlm.nih.gov/pubmed/36217728 http://dx.doi.org/10.1177/10760296221126172 |
_version_ | 1784807534369964032 |
---|---|
author | Godtfredsen, Anne Cathrine Sidelmann, Johannes Jakobsen Dolleris, Britta Blume Jørgensen, Jan Stener Johansen, Emma Kathrine Jungjohan Pedersen, Melissa Fernard Bøg Palarasah, Yaseelan Gram, Jørgen Brodersen |
author_facet | Godtfredsen, Anne Cathrine Sidelmann, Johannes Jakobsen Dolleris, Britta Blume Jørgensen, Jan Stener Johansen, Emma Kathrine Jungjohan Pedersen, Melissa Fernard Bøg Palarasah, Yaseelan Gram, Jørgen Brodersen |
author_sort | Godtfredsen, Anne Cathrine |
collection | PubMed |
description | OBJECTIVES: Preeclampsia (PE) is a serious complication of pregnancy. The fibrinolytic system play crucial roles regarding placentation and evolution of PE. AIM: To study comprehensively components of the fibrinolytic system and fibrin lysability in women with PE. DESIGN AND METHODS: 117 women with PE and matched controls were included. Tissue type plasminogen activator (t-PA), plasminogen, PAI-1, plasmin inhibitor (PI), D-dimer, the fibrinolytic potential of dextran sulphate euglobulin fraction (DEF), PAI-2, polymere PAI-2, fibrin clot lysability, thrombin activatable fibrinolysis inhibitor (TAFI) and fibrinogen were assessed. RESULTS: Women with PE had significantly increased concentrations of t-PA and PAI-1, whereas the plasma concentration of PAI-2 was significantly lower compared to controls, p < 0.0001. Polymere PAI-2 was detected in both groups. DEF, TAFI and fibrinogen were not different between the groups. D-dimer was significantly increased and plasminogen/PI together with fibrin clot lysability time decreased in the PE-group, p = 0.0004 p = 0.04, p = 0.03, p < 0.0001 respectively. CONCLUSION: This study demonstrates that PE is associated with an affected t-PA/PAI-1 system, decreased PAI-2 and increased fibrin lysability. Furthermore, PAI-2 has the potential to polymerize during pregnancy. |
format | Online Article Text |
id | pubmed-9558852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-95588522022-10-14 Fibrinolytic Changes in Women with Preeclampsia Godtfredsen, Anne Cathrine Sidelmann, Johannes Jakobsen Dolleris, Britta Blume Jørgensen, Jan Stener Johansen, Emma Kathrine Jungjohan Pedersen, Melissa Fernard Bøg Palarasah, Yaseelan Gram, Jørgen Brodersen Clin Appl Thromb Hemost Original Manuscript OBJECTIVES: Preeclampsia (PE) is a serious complication of pregnancy. The fibrinolytic system play crucial roles regarding placentation and evolution of PE. AIM: To study comprehensively components of the fibrinolytic system and fibrin lysability in women with PE. DESIGN AND METHODS: 117 women with PE and matched controls were included. Tissue type plasminogen activator (t-PA), plasminogen, PAI-1, plasmin inhibitor (PI), D-dimer, the fibrinolytic potential of dextran sulphate euglobulin fraction (DEF), PAI-2, polymere PAI-2, fibrin clot lysability, thrombin activatable fibrinolysis inhibitor (TAFI) and fibrinogen were assessed. RESULTS: Women with PE had significantly increased concentrations of t-PA and PAI-1, whereas the plasma concentration of PAI-2 was significantly lower compared to controls, p < 0.0001. Polymere PAI-2 was detected in both groups. DEF, TAFI and fibrinogen were not different between the groups. D-dimer was significantly increased and plasminogen/PI together with fibrin clot lysability time decreased in the PE-group, p = 0.0004 p = 0.04, p = 0.03, p < 0.0001 respectively. CONCLUSION: This study demonstrates that PE is associated with an affected t-PA/PAI-1 system, decreased PAI-2 and increased fibrin lysability. Furthermore, PAI-2 has the potential to polymerize during pregnancy. SAGE Publications 2022-10-11 /pmc/articles/PMC9558852/ /pubmed/36217728 http://dx.doi.org/10.1177/10760296221126172 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Manuscript Godtfredsen, Anne Cathrine Sidelmann, Johannes Jakobsen Dolleris, Britta Blume Jørgensen, Jan Stener Johansen, Emma Kathrine Jungjohan Pedersen, Melissa Fernard Bøg Palarasah, Yaseelan Gram, Jørgen Brodersen Fibrinolytic Changes in Women with Preeclampsia |
title | Fibrinolytic Changes in Women with Preeclampsia |
title_full | Fibrinolytic Changes in Women with Preeclampsia |
title_fullStr | Fibrinolytic Changes in Women with Preeclampsia |
title_full_unstemmed | Fibrinolytic Changes in Women with Preeclampsia |
title_short | Fibrinolytic Changes in Women with Preeclampsia |
title_sort | fibrinolytic changes in women with preeclampsia |
topic | Original Manuscript |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558852/ https://www.ncbi.nlm.nih.gov/pubmed/36217728 http://dx.doi.org/10.1177/10760296221126172 |
work_keys_str_mv | AT godtfredsenannecathrine fibrinolyticchangesinwomenwithpreeclampsia AT sidelmannjohannesjakobsen fibrinolyticchangesinwomenwithpreeclampsia AT dollerisbrittablume fibrinolyticchangesinwomenwithpreeclampsia AT jørgensenjanstener fibrinolyticchangesinwomenwithpreeclampsia AT johansenemmakathrinejungjohan fibrinolyticchangesinwomenwithpreeclampsia AT pedersenmelissafernardbøg fibrinolyticchangesinwomenwithpreeclampsia AT palarasahyaseelan fibrinolyticchangesinwomenwithpreeclampsia AT gramjørgenbrodersen fibrinolyticchangesinwomenwithpreeclampsia |